EE25 Economic Benefit of Faricimab Compared to Aflibercept 8mg in Treating Patients with Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the United States
Abstract
Authors
D Tabano Moustaid F El KL Rosettie S Ko E Meer FL Brodie